JP2004531241A - ヒトａｂｃｃ１１遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 - Google Patents

ヒトａｂｃｃ１１遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 Download PDF

Info

Publication number
JP2004531241A
JP2004531241A JP2002571545A JP2002571545A JP2004531241A JP 2004531241 A JP2004531241 A JP 2004531241A JP 2002571545 A JP2002571545 A JP 2002571545A JP 2002571545 A JP2002571545 A JP 2002571545A JP 2004531241 A JP2004531241 A JP 2004531241A
Authority
JP
Japan
Prior art keywords
nucleic acid
abcc11
polypeptide
nucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002571545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004531241A5 (enExample
Inventor
マリー・ロジエ−モンテュス
カトリン・プラデ
イザベル・アルヌール−レギン
マイクル・ディーン
ランドー・アリクメッツ
パトリス・デネフル
Original Assignee
アベンティス・ファーマ・ソシエテ・アノニム
ザ・ガバメント・オブ・ザ・ユナイテッド・ステイツ・オブ・アメリカ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アベンティス・ファーマ・ソシエテ・アノニム, ザ・ガバメント・オブ・ザ・ユナイテッド・ステイツ・オブ・アメリカ filed Critical アベンティス・ファーマ・ソシエテ・アノニム
Publication of JP2004531241A publication Critical patent/JP2004531241A/ja
Publication of JP2004531241A5 publication Critical patent/JP2004531241A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
JP2002571545A 2001-03-05 2002-03-05 ヒトａｂｃｃ１１遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用 Pending JP2004531241A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27275701P 2001-03-05 2001-03-05
PCT/EP2002/003241 WO2002072632A2 (en) 2001-03-05 2002-03-05 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.

Publications (2)

Publication Number Publication Date
JP2004531241A true JP2004531241A (ja) 2004-10-14
JP2004531241A5 JP2004531241A5 (enExample) 2005-12-22

Family

ID=23041140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571545A Pending JP2004531241A (ja) 2001-03-05 2002-03-05 ヒトａｂｃｃ１１遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用

Country Status (5)

Country Link
US (2) US6893841B2 (enExample)
EP (1) EP1385884A2 (enExample)
JP (1) JP2004531241A (enExample)
CA (1) CA2439702A1 (enExample)
WO (1) WO2002072632A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4967135B2 (ja) * 2005-06-17 2012-07-04 国立大学法人 長崎大学 耳垢型又は腋下臭症の評価方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370585A2 (en) * 2001-03-05 2003-12-17 Aventis Pharma S.A. Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
US7049120B2 (en) * 2001-03-09 2006-05-23 Bayer Healthcare Ag Regulation of human mrp5-like protein
US20080025981A1 (en) * 2002-03-04 2008-01-31 Young Paul E Cancer-linked genes as targets for chemotherapy
US20040001840A1 (en) * 2002-03-04 2004-01-01 Young Paul E. Cancer-linked gene as target for chemotherapy
US20040049399A1 (en) * 2002-09-10 2004-03-11 Elisabeth Familian Method and system for online donation and sending customized card

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390182A1 (en) * 1999-11-02 2001-05-10 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
WO2002016589A2 (en) * 2000-08-21 2002-02-28 Millennium Pharmaceuticals, Inc. Human abc transporter family member and uses thereof
EP1474528A4 (en) * 2000-10-13 2006-06-14 Protein Design Labs Inc METHODS FOR DIAGNOSING PROSTATE CANCER, COMPOSITIONS AND METHODS FOR SCREENING PROSTATE CANCER MODULATORS
EP1370585A2 (en) * 2001-03-05 2003-12-17 Aventis Pharma S.A. Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4967135B2 (ja) * 2005-06-17 2012-07-04 国立大学法人 長崎大学 耳垢型又は腋下臭症の評価方法

Also Published As

Publication number Publication date
CA2439702A1 (en) 2002-09-19
EP1385884A2 (en) 2004-02-04
US6893841B2 (en) 2005-05-17
WO2002072632A3 (en) 2003-11-27
WO2002072632A2 (en) 2002-09-19
US20030059793A1 (en) 2003-03-27
US20050158784A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
JP5328603B2 (ja) 良性の家族性新生児痙攣（ｂｆｎｃ）および他の癲癇において突然変異されたｋｃｎｑ２およびｋｃｎｑ３−カリウムチャンネル遺伝子
JP2004526444A (ja) Ｓｔｅａｐ関連タンパク質
CA2391621A1 (en) Novel variants of the human cyp2d6 gene
FR2806739A1 (fr) Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
JP2004505631A (ja) リシルオキシダーゼ遺伝子ファミリーの新規メンバー
US6893841B2 (en) Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
AU5238999A (en) Isoforms of human calcium sensing receptor
EP1213352A1 (en) Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
EP1096012A1 (en) Nucleics acids of the human ABC1 gene and their therapeutic and diagnostic application
JPWO2000029571A1 (ja) 新規膜貫通蛋白質をコードする遺伝子
US20030087246A1 (en) Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
JP2004508003A (ja) 一ヌクレオチド多型を含む核酸およびその使用方法
JP2004537971A (ja) 大腸癌マーカー
US6998474B1 (en) Polypeptides of the “basic helix-loop-helix” bHLH family, corresponding nucleic acid sequences
JP2004537983A (ja) ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用
US20060063166A1 (en) Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids and uses thereof
KR20020012279A (ko) 인간 유전자 에이비씨1에 상응하는 핵산 및 단백질
JP4548938B2 (ja) Ｍｅｋｋ１（セリントレオニンキナーゼ）相互作用性ｆｈａ（フォークヘッド結合ドメイン）タンパク質１（ｍｉｆ１）
US20030077605A1 (en) Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids, and uses thereof
JP2005503107A (ja) Ａｓｉｐ関連タンパク質
JP2005504504A (ja) ＴＩＭＭ８ｂ関連タンパク質
FR2824332A1 (fr) Acide nucleique codant le polypeptide cgl1 et application de cet acide nucleique et du polypeptide cgl1 au diagnostic et en therapeutique
KR20020059645A (ko) 인간 에이비씨1 유전자의 핵산과 이의 치료적 및 진단적적용

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080401